No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.

In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research ...

A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...

COVID-19 appears to be on the rise in some parts of California as a new, highly contagious subvariant — featuring 'razor blade throat' symptoms overseas — is becoming increasingly dominant.

An experimental weight loss drug from Eli Lilly & Co. helped patients lose weight with few side effects, according to the summary of a small study that suggests the company has another foothold in ...

A surprising new study has found that some common medication used to make people feel better might also be effective in the fight against cancer.

A new study from UCLA Health suggests COVID-19 vaccines may protect patients from severe kidney damage. The study found hospitalized COVID-19 patients were less likely to have severe kidney damage ...

Researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed a compound that could work as a broad-spectrum drug targeting a range of coronaviruses. Their ...

A team led by the University of Sydney has identified red blood cell rupture at dying endothelial sites as a primary driver of microvascular obstruction in COVID-19, bypassing the expected role of ...

GLP-1 drugs “alter taste perception” and "disrupt the perception of sweetness, bitterness, fatty foods and even mouthfeel”, a study says.

The Commissioner of the Food and Drug Administration is promising a full agency review of the safety of chemical abortion drug mifepristone after a new study raised concerns about its effects.